drugset / Trial / NCT01333605
IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The aim of study is to prove IGEV regimen followed by autologous stem cell transplantation as salvage treatment in patients with refractory or relapsed Hodgkin lymphoma is effective.
Timeline
- Start
- 2011-04
- Primary completion
- 2014-04
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | 400 mg | — |
| Subject | Gemcitabine | Small molecule | 800 mg/m2 | — |
| Subject | Ifosfamide | Small molecule | 1200 mg/m2 | — |
| Subject | Prednisone | Other / unclassified | 100 mg | — |
| Subject | Vinorelbine | Small molecule | 20 mg/m2 | — |